<VariationArchive VariationID="627011" VariationName="NM_024747.6(HPS6):c.155del (p.Val52fs)" VariationType="Deletion" Accession="VCV000627011" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2019-09-29" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="615424" VariationID="627011">
      <GeneList>
        <Gene Symbol="HPS6" FullName="HPS6 biogenesis of lysosomal organelles complex 2 subunit 3" GeneID="79803" HGNC_ID="HGNC:18817" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065349" stop="102068036" display_start="102065349" display_stop="102068036" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103825123" stop="103827794" display_start="103825123" display_stop="103827794" Strand="+" />
          </Location>
          <OMIM>607522</OMIM>
        </Gene>
        <Gene Symbol="LOC130004578" FullName="ATAC-STARR-seq lymphoblastoid silent region 2738" GeneID="130004578" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065101" stop="102065770" display_start="102065101" display_stop="102065770" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_024747.6(HPS6):c.155del (p.Val52fs)</Name>
      <CanonicalSPDI>NC_000010.11:102065628:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102065629" stop="102065629" display_start="102065629" display_stop="102065629" variantLength="1" positionVCF="102065628" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="103825386" stop="103825386" display_start="103825386" display_stop="103825386" variantLength="1" positionVCF="103825385" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V52fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_564" sequenceAccession="LRG_564">
            <Expression>LRG_564:g.5240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024747.5" sequenceAccession="NM_024747" sequenceVersion="5" change="c.155delT">
            <Expression>NM_024747.5:c.155delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.103825386del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.103825386del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102065629del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102065629del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012029.1" sequenceAccession="NG_012029" sequenceVersion="1" change="g.5240del">
            <Expression>NG_012029.1:g.5240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024747.6" sequenceAccession="NM_024747" sequenceVersion="6" change="c.155del" MANESelect="true">
            <Expression>NM_024747.6:c.155del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079023.2" sequenceAccession="NP_079023" sequenceVersion="2" change="p.Val52fs">
            <Expression>NP_079023.2:p.Val52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1590262450" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024747.6(HPS6):c.155del (p.Val52fs) AND Hermansky-Pudlak syndrome" Accession="RCV000851709" Version="1">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024747.6(HPS6):c.155del (p.Val52fs) AND not provided" Accession="RCV003558571" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-09-29" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27593200</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33878481</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1769233" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.155delT_C0079504" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899527" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>East-Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0177</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024747.5:c.155delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0079504" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7980665" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4887465|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004295694" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33878481</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27593200</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31064749</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the HPS6 protein in which other variant(s) (p.Arg667*) have been determined to be pathogenic (PMID: 33878481; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 627011). This premature translational stop signal has been observed in individual(s) with HPS6-related conditions (PMID: 27593200, 31064749). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val52Glufs*6) in the HPS6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 724 amino acid(s) of the HPS6 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.103825386del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1769233" TraitType="Disease" MappingType="Name" MappingValue="Hermansky-Pudlak syndrome" MappingRef="Preferred">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7980665" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

